Sunday - May 4, 2025
CHICAGO / Jan 29, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) has been named to 2025 Fortune World’s Most Admired Companies™ list. The company has been recognized across several categories including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets.
Being named to Fortune World’s Most Admired Companies™ list for the first time, two years after becoming an independent company, is a testament to GE HealthCare’s progress against its precision care strategy across disease states, enabling colleagues to deliver innovations that improve clinical workflows and help clinicians make more precise diagnoses and improve patient outcomes.
“This recognition is a testament to the dedication of our 51,000 global colleagues who help deliver our precision care strategy to best serve our patients and customers,” said Peter Arduini, President and CEO at GE HealthCare. “Our entrepreneurial and inclusive culture ensures that the broad perspectives and expertise of our teams continue to build our 125-year legacy of innovation, advance our purpose-driven strategy and help make a meaningful impact on healthcare worldwide.”
A company's score must rank in the top half of its industry survey to be listed. The ranking is considered the “gold standard” for employee-centric companies, highlighting employers who have created an exemplary work environment. For more information and to view the complete list of companies, visit: http://fortune.com/worlds-most-admired-companies/.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
From Fortune, ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Fortune is a registered trademark and Fortune World’s Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of GE HealthCare.
Last Trade: | US$70.53 |
Daily Change: | 2.86 4.23 |
Daily Volume: | 7,032,428 |
Market Cap: | US$32.220B |
May 02, 2025 April 30, 2025 April 10, 2025 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load